This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Etomidate

Read time: 1 mins
Marketing start date: 26 Nov 2024
...
 

Summary of product characteristics


Effective Time

20221017

Version

5

Spl Product Data Elements

etomidate etomidate ETOMIDATE ETOMIDATE PROPYLENE GLYCOL

Application Number

ANDA202360

Brand Name

Etomidate

Generic Name

etomidate

Product Ndc

65841-818

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Vial Label 10 mL Zydus Pharmaceuticals NDC 65841-818-07 Etomidate Injection, USP 20 mg/10 mL (2 mg/mL) For Intravenous Use 10 mL, Single-Dose Vial Rx Only Carton Label 10 mL Zydus Pharmaceuticals NDC 65841-818-07 Etomidate injection, USP 20 mg/10 mL (2 mg/mL) For Intravenous Use 10 x 10 mL, Single-Dose Vials Rx Only Vial Label 20 mL Zydus Pharmaceuticals NDC 65841-818-08 Etomidate injection, USP 40 mg/20 mL (2 mg/mL) For Intravenous Use 20 mL, Single-Dose Vial Rx Only Carton Label 20 mL Zydus Pharmaceuticals NDC 65841-818-08 Etomidate injection, USP 40 mg/20 mL (2 mg/mL) For Intravenous Use 10 x 20 mL, Single-Dose Vials Rx Only figure02 figure03 figure04 figure05

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.